Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NATIONAL INSTITUTES OF HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary, Private

Established: 1948-01-01

Employees: 1K

Market Cap: -

Website: http://www.nidcr.nih.gov

Clinical Trials

Colorectal Neoplasia Screening w Colonoscopy in Asymptomatic Women at Regional Navy/Army Medical Ctrs: The CONCeRN Trial

Completed

Conditions: Colorectal Adenoma

First Posted Date: 2006-06-21

Last Posted Date: 2020-07-17

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 937

Registration Number: NCT00339950

Locations: 🇺🇸
Naval Medical Center, San Diego, San Diego, California, United States
🇺🇸
National Naval Medical Center, Bethesda, Maryland, United States
🇺🇸
Naval Medical Center, Portsmouth, Portsmouth, Virginia, United States

Genetic Epidemiology of Lung Cancer and Smoking

Completed

Conditions: Lung Cancer

First Posted Date: 2006-06-21

Last Posted Date: 2020-06-30

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 4429

Registration Number: NCT00340340

Locations: 🇮🇹
Spedali Civili, Brescia, Italy
🇮🇹
Instituto Clinica Humanitas - ICH, Rozzano-Milan, Italy
🇮🇹
Azienda Ospedaliera Luigi Sacco, Milano, Italy

and more 15 locations

Molecular Genetics Study of Nasopharyngeal Carcinoma: Characterization of NCP Susceptibility Gene(s)

Completed

Conditions: Nasopharyngeal Carcinoma

First Posted Date: 2006-06-21

Last Posted Date: 2020-06-16

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 6490

Registration Number: NCT00341146

Locations: 🇨🇳
Institute for Viral Disease Control & Prevention, Beijing, China

Breast Cancer in Poland: An Expanded Study to Assess Occupational and Environmental Factors and Interactions With Genetics

Completed

Conditions: Ovarian Neoplasms
Gonadal Disorders
Uterine Diseases
Endometrial Neoplasms
Breast Neoplasms

First Posted Date: 2006-06-21

Last Posted Date: 2020-04-20

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 6086

Registration Number: NCT00341458

Locations: 🇵🇱
Nofer Institute of Occupational Medicine, Lodz, Poland
🇵🇱
Maria Sklodowska Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland

Analyses of Human Samples Collected in Clinical Trials

Completed

Conditions: Neoplasm Metastasis
Leukemia, Lymphoid
Prostate Cancer
Leukemia, Myeloid

First Posted Date: 2006-06-21

Last Posted Date: 2020-03-30

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 2579

Registration Number: NCT00339664

Locations: 🇺🇸
Childrens National Medical Center, Washington, District of Columbia, United States
🇺🇸
H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States
🇺🇸
University of Chicago, Chicago, Illinois, United States

and more 14 locations

Cervical Cancer Early Endpoints and Determinants

Completed

Conditions: Cervical Intraepithelial
Neoplasia
CIN
Cervical Cancer

First Posted Date: 2006-06-21

Last Posted Date: 2020-03-13

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 3013

Registration Number: NCT00339989

Locations: 🇺🇸
University of Oklahoma, Oklahoma City, Oklahoma, United States

Biomarkers for Oral Cancer

Active, not recruiting

Conditions: Oral Leukoplakia
Mouth Neoplasms
Lichen Planus

First Posted Date: 2006-06-21

Last Posted Date: 2025-06-26

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 80

Registration Number: NCT00341497

Locations: 🇺🇸
VA Medical Center, Durham, Durham, North Carolina, United States
🇺🇸
Veterans Affairs, San Antonio, San Antonio, Texas, United States
🇺🇸
VA Medical Ctr, Atlanta, Atlanta, Georgia, United States

and more 3 locations

Collection and Distribution of Samples From Healthy Donors for In Vitro Research at the NCI-Frederick

Conditions: Healthy Donors

First Posted Date: 2006-06-21

Last Posted Date: 2025-06-26

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 1200

Registration Number: NCT00339911

Locations: 🇺🇸
NCI Frederick Cancer Research Center, Frederick, Maryland, United States

Nutrition Intervention Trials in Linxian Follow-up Study

Conditions: Esophageal Cancer
Gastric Cancer

First Posted Date: 2006-06-21

Last Posted Date: 2025-06-26

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 34000

Registration Number: NCT00342654

Locations: 🇨🇳
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, China

Eribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Phase 2

Completed

Conditions: Adenocarcinoma of the Prostate
Hormone-refractory Prostate Cancer
Recurrent Prostate Cancer
Stage IV Prostate Cancer

Interventions: Drug: eribulin mesylate

First Posted Date: 2006-06-15

Last Posted Date: 2014-06-23

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 121

Registration Number: NCT00337077

Locations: 🇺🇸
Sparrow Hospital, Lansing, Michigan, United States
🇺🇸
Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
🇺🇸
Virtua West Jersey Hospital Voorhees, Voorhees, New Jersey, United States

and more 143 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy